Adults With Obesity More Likely to Ration Drugs to Save Money. Adults with obesity are more likely to ration their ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

The current pain caused by the high cost of the GLP-1 agonist anti-obesity drugs will pass. Prachi Patkee and other analysts ...

Danish biotech Gubra A/S said its experimental obesity drug showed weight loss and mild side effects in a small study, ...

On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value.

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...